Eszopiclone Press Articles
JCN Newswires - Eisai to Launch Insomnia Treatment Lunesta® in Japan
Posted by admin / Under EszopicloneApril 17, 2012 --
Tokyo, Apr 17, 2012 - (JCN Newswire) - Eisai Co., Ltd. announced today that it will launch the insomnia treatment Lunesta(R) (eszopiclone) in...
Published on Friday 18th of May 2012 04:46:11 PM
Read more...
Access - What keeps you up at night? The prevalence of insomnia and treatment with nonbenzodiazepine sedative hypnotics
Posted by admin / Under EszopicloneJuly 1, 2011 --
Patient: "My wife just passed away from a long battle with cancer." Patient: "I know I need quadrant scaling and root...
Published on Friday 18th of May 2012 04:46:11 PM
Read more...
Business Wire - Sepracor Granted Patent Term Extension for LUNESTA® and Provides Update on LUNESTA Pediatric Studies
Posted by admin / Under EszopicloneDecember 1, 2009 -- HASH(0x2a966b15f0)
- LUNESTA patent term extended by 760 days to February 14,...
Published on Friday 18th of May 2012 04:46:11 PM
Read more...
Business Wire - Sepracor Files Patent Infringement Lawsuit Against Eszopiclone ANDA Filers
Posted by admin / Under EszopicloneMarch 20, 2009 --
MARLBOROUGH, Mass. -- Sepracor Inc. (Nasdaq: SEPR) today announced that it has filed a lawsuit in the U.S. District Court for the...
Published on Friday 18th of May 2012 04:46:11 PM
Read more...
Business Wire - Sepracor Reports Preliminary Phase II Study Results for SEP-225441 for the Treatment of Generalized Anxiety Disorder
Posted by admin / Under EszopicloneMarch 5, 2009 --
MARLBOROUGH, Mass. -- Sepracor Inc. (Nasdaq: SEPR) today announced that it has completed the analysis and validation of the...
Published on Friday 18th of May 2012 04:46:11 PM
Read more...
